Olpasiran

Modify Date: 2024-01-09 16:05:20

Use of Olpasiran

Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver.

Name	Olpasiran

Description	Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver.
Related Catalog	Research Areas >> Cardiovascular Disease
References	[1]. Sohn W, Winkle P, Neutel J, et al. Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study. Clin Ther. 2022;44(9):1237-1247. [2]. O'Donoghue ML, G López JA, Knusel B, et al. Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE). Am Heart J. 2022;251:61-69.

Description

Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver.

Related Catalog

Research Areas >> Cardiovascular Disease

References

No Any Chemical & Physical Properties